Yeleswaram Krishnaswamy
SEC CIK 2022156 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | Chief Development Off | 195.9K | — | $4.46M | 8 | 2025-12-31 | 2026-08-24 |
Most active insiders at RAPP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Third Rock Ventures V, L.P. | 10% | — | $34.39M |
| 2 | Ceesay Abraham | CEO, Dir | — | $6.07M |
| 3 | Yeleswaram Krishnaswamy | Chief Development Off | — | $4.46M |
| 4 | Bredt David | CSO | — | $1.36M |
| 5 | Gault Cheryl | COO | — | $906.4K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-08-26 16:00 | 2026-08-24+ | RAPP | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Off | S - Sale | $50.47 | -50.2K | 195.9K | -20% | -$2.53M |
| T | 2026-08-20 16:09 | 2026-08-19 | RAPP | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Off | S - Sale | $49.90 | -404 | 246.0K | -0.2% | -$20.2K |
| T | 2026-04-21 16:55 | 2026-04-17 | RAPP | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Off | S - Sale | $39.99 | -20.2K | 246.4K | -8% | -$808.8K |
| MT | 2026-04-14 16:13 | 2026-04-10+ | RAPP | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Off | S - Sale | $35.03 | -19.9K | 266.7K | -7% | -$695.8K |
| T | 2026-04-09 16:30 | 2026-04-08 | RAPP | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Off | S - Sale | $34.90 | -360 | 286.5K | -0.1% | -$12.6K |
| T | 2026-03-26 | 2026-03-25 | RAPP | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Off | S - Sale | $29.99 | -10.1K | 286.9K | -3% | -$303.3K |
| 2026-01-05 | 2025-12-31 | RAPP | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Off | A - Grant | — | +9,000 | 299.8K | +3% | — | |
| 2026-01-05 | 2025-12-31 | RAPP | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Chief Development Off | S - Sale | $30.05 | -2,840 | 297.0K | -0.9% | -$85.3K |
Purchase Sale Sale after option exercise All abbreviations